Concepedia

Ryohei Yoshida

RY

9

Publications

822

Citations

9

H-Index

2017

Active since

Affiliations

Asahikawa Medical University(Current)

Japanese Foundation For Cancer Research

Brigham and Women's Hospital

Sapporo Higashi Tokushukai Hospital

Brown University

Ryohei Yoshida is an author at Asahikawa Medical University specializing in medicine, lung cancer, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2022

9

Publications

9

Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo et al. · Cancer Discovery · 2018 · 489 citations

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 90 citations · Full text

, , +4

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report

Yoshitsugu Narumi, Ryohei Yoshida, Yoshinori Minami et al. · BMC Cancer · 2018 · 63 citations · Full text

Tumor-Derived cGAMP Regulates Activation of the Vasculature

Marco Campisi, Shriram K. Sundararaman, Sarah E. Shelton et al. · Frontiers in Immunology · 2020 · 56 citations · Full text

, , +18

Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer

Ryohei Yoshida, Takaaki Sasaki, Yoshinori Minami et al. · International Journal of Oncology · 2017 · 33 citations · Full text

, , +17

Rows per page

1–5 of 9